1-6 of 6
Jorge A. Carrasquillo, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 ( 225 Ac)-Lintuzumab (Anti-CD33; HuM195) in Acute Myeloid Leukemia (AML)

Joseph G. Jurcic, MD, Todd L. Rosenblat, MD, Michael R. McDevitt, PhD, Neeta Pandit-Taskar, MD, Jorge A. Carrasquillo, MD, Suzanne M. Chanel, RN, Kevin Zikaras, BS, Mark G. Frattini, MD, PhD, Peter G. Maslak, M.D., Dragan Cicic, MD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 768.
https://doi.org/10.1182/blood.V118.21.768.768
Published: 2011
Journal Articles

Yttrium-90 Radiolabeled Daclizumab, An Anti-CD25 Monoclonal Antibody, Provides Effective Therapy for Refractory and Relapsed Hodgkin's Lymphoma,

Thomas A. Waldmann, MD, John Janik, MD, John C Morris, Kevin Conlon, Deirdre O'Mahony, MB, BCh, BAO, MRCP(UK), MSc, Stefania Pittaluga, Elaine S. Jaffe, MD, Martin Brechbiel, Chang H Paik, Clara Chen, Millie Whatley, CNMT, Thomas A Fleisher, Jeffrey White, MD, Donn Stewart, Suzanne Fioravanti, Carolyn Goldman, Bonita Bryant, Jean Decker, Richard Junghans, Jorge A. Carrasquillo, MD
Journal: Blood
Blood (2011) 118 (21): 3706.
https://doi.org/10.1182/blood.V118.21.3706.3706
Published: 2011
Journal Articles

Yttrium-90 Radiolabeled Humanized Monoclonal Antibody to CD25 in Refractory and Relapsed Hodgkin’s Lymphoma

Deirdre O’Mahony, MD, John E Janik, MD, Jorge A. Carrasquillo, MD, Pamela Seam, MD, Joseph A Fiorillo, MD, Donn Stewart, MD, Chang H Paik, PhD, Suzanne Fioravanti, RN, Millie Whatley, RNMT, Stefania Pittaluga, MD, PhD, Martin W Brechbiel, PhD, John C Morris, MD, Thomas A Waldmann, MD
Journal: Blood
Blood (2008) 112 (11): 231.
https://doi.org/10.1182/blood.V112.11.231.231
Published: 2008
Journal Articles

Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients

Kieron Dunleavy, MD, Richard Little, MD, Alan S. Wayne, MD, Nicole Grant, MPH, Stefania Pittaluga, MD, PhD, Elaine S. Jaffe, MD, Seth Steinberg, PhD, Robert Yarchoan, MD, PhD, Jorge A. Carrasquillo, MD, John E. Janik, MD, Wyndham H. Wilson, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3606.
https://doi.org/10.1182/blood.V112.11.3606.3606
Published: 2008
Journal Articles

Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 ( 225 Ac)-HuM195 (Anti-CD33) in Acute Myeloid Leukemia (AML).

Todd L. Rosenblat, MD, Michael R. McDevitt, PhD, Neeta Pandit-Taskar, MD, Jorge A. Carrasquillo, MD, Suzanne Chanel, RN, Mark G. Frattini, MD, PhD, Steven M. Larson, MD, David A. Scheinberg, MD, PhD, Joseph G. Jurcic, MD
Journal: Blood
Blood (2007) 110 (11): 910.
https://doi.org/10.1182/blood.V110.11.910.910
Published: 2007
Journal Articles

Whole-Body Positron Emission Tomography (PET) Using 2- 18 Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS).

V. Koneti Rao, MD, Jorge A. Carrasquillo, MD, Janet K. Dale, RN, MPH, Stephen Bacharach, PhD, Millie Whatley, RNMT, Faith Dugan, RN, Jean Tretler, RN, Elaine S. Jaffe, MD, Wyndham Wilson, MD, Nilo Avila, MD, Stephen E. Straus, MD
Journal: Blood
Blood (2004) 104 (11): 3850.
https://doi.org/10.1182/blood.V104.11.3850.3850
Published: 2004